CAR T-cell Cytotoxicity of Solid Tumors is Dependent on IFNγR Signaling & Downstream Adhesion

CAR T-cell Cytotoxicity of Solid Tumors is Dependent on IFNγR Signaling & Downstream AdhesionПодробнее

Increasing Epitope Spreading to Improve CAR T Therapy for Solid TumorsПодробнее

Engineering chimeric antigen receptor modified T cells against solid tumorПодробнее

How cell and gene therapies can transform the treatment of solid tumoursПодробнее

Current challenges in targeting solid tumors with CAR T-cellsПодробнее

CAR T Cells: Beating Cancer with the Immune SystemПодробнее

CAR T Cell Immunotherapy of Solid Tumors Learning from the Clinic and Lab in ParallelПодробнее

Barriers to using CAR T-cells in solid tumors and strategies to overcome themПодробнее

Challenges associated with CAR-T cells in solid tumorsПодробнее

Updates in CAR T Cell TherapiesПодробнее

Label-free Live Cell Imaging: Activated T-Cell Killing Cancer CellПодробнее

Side Effects of CAR T Cell TherapyПодробнее

Enabling CAR T cells in solid tumors by checkpoint blockadeПодробнее

Activated T cell attacks a cancer cellПодробнее

The application of CAR T-cell therapy for solid tumorsПодробнее

What You Need To Know About CAR T-Cell TherapyПодробнее

Challenges with implementing CAR-T approaches in solid tumorsПодробнее

Mesothelin-specific CAR-T Cell Therapy with HLA-gated Safety Mechanism Selectively Kills Tumor CellsПодробнее

Expert Addresses Role of CAR T-Cell Therapy in Solid TumorsПодробнее

Chimeric Antigen Receptor (CAR) T-Cell Therapy Video Series (Teaser)Подробнее